These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15196322)

  • 1. Iron supplementation in the intensive care unit: when, how much, and by what route?
    Lapointe M
    Crit Care; 2004; 8 Suppl 2(Suppl 2):S37-41. PubMed ID: 15196322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bench-to-bedside review: iron metabolism in critically ill patients.
    Darveau M; Denault AY; Blais N; Notebaert E
    Crit Care; 2004 Oct; 8(5):356-62. PubMed ID: 15469598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Review by expert group in the diagnosis and treatment of anemia in pregnant women. Federación Mexicana de Colegios de Obstetricia y Ginecología].
    Montoya Romero Jde J; Castelazo Morales E; Valerio Castro E; Velázquez Cornejo G; Nava Muñoz DA; Escárcega Preciado JA; Montoya Cossío J; Pichardo Villalón GM; Maldonado Aragón A; Santana García HR; Fajardo Dueñas S; Mondragón Galindo CG; García Lee T; García A; Hernández de Morán M; Chávez Güitrón LE; Jiménez Gutiérrez C;
    Ginecol Obstet Mex; 2012 Sep; 80(9):563-80. PubMed ID: 23243836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of high-dose oral iron supplementation during erythropoietin therapy for anemia of prematurity.
    Bader D; Kugelman A; Maor-Rogin N; Weinger-Abend M; Hershkowitz S; Tamir A; Lanir A; Attias D; Barak M
    J Perinatol; 2001 Jun; 21(4):215-20. PubMed ID: 11533837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of IV iron compared to oral iron for increment of haemoglobin level in anemic chronic kidney disease patients on erythropoietin therapy.
    Adhikary L; Acharya S
    JNMA J Nepal Med Assoc; 2011; 51(183):133-6. PubMed ID: 22922860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis.
    Charytan C; Qunibi W; Bailie GR;
    Nephron Clin Pract; 2005; 100(3):c55-62. PubMed ID: 15824508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of erythropoiesis-stimulating agents in the intensive care unit.
    Piagnerelli M; Vincent JL
    Crit Care Clin; 2012 Jul; 28(3):345-62, v. PubMed ID: 22713610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parenteral iron dextran therapy: a review.
    Burns DL; Mascioli EA; Bistrian BR
    Nutrition; 1995; 11(2):163-8. PubMed ID: 7647482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anemia of chronic disorder - pathogenesis, clinical presentation and treatment].
    Demarmels Biasiutti F
    Ther Umsch; 2010 May; 67(5):225-8. PubMed ID: 20509118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron management during recombinant human erythropoietin therapy.
    Van Wyck DB
    Am J Kidney Dis; 1989 Aug; 14(2 Suppl 1):9-13. PubMed ID: 2757026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of intravenous iron dextran and oral iron in inflammatory bowel disease: a case-matched study in clinical practice.
    Khalil A; Goodhand JR; Wahed M; Yeung J; Ali FR; Rampton DS
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(11):1029-35. PubMed ID: 21857526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anaphylaxis after iron dextran administration in a pregnant woman].
    Kortenhorst MS; Harmsze AM; Hasaart TH
    Ned Tijdschr Geneeskd; 2012; 156(48):A5264. PubMed ID: 23191972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial.
    Auerbach M; Ballard H; Trout JR; McIlwain M; Ackerman A; Bahrain H; Balan S; Barker L; Rana J
    J Clin Oncol; 2004 Apr; 22(7):1301-7. PubMed ID: 15051778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron metabolism and iron substitution during erythropoietin therapy.
    Sunder-Plassmann G; Hörl WH
    Clin Investig; 1994; 72(6 Suppl):S11-5. PubMed ID: 7950165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early erythropoietin influences both transfusion and ventilation need in very low birth weight infants.
    Tempera A; Stival E; Piastra M; De Luca D; Ottaviano C; Tramontozzi P; Marconi M; Cafforio C; Marcozzi P; Rossi N; Buffone E
    J Matern Fetal Neonatal Med; 2011 Aug; 24(8):1060-4. PubMed ID: 21250913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron supplementation in renal anemia.
    Fishbane S
    Semin Nephrol; 2006 Jul; 26(4):319-24. PubMed ID: 16949471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supplementation with oral vs. intravenous iron for anemia with IBD or gastrointestinal bleeding: is oral iron getting a bad rap?
    Rizvi S; Schoen RE
    Am J Gastroenterol; 2011 Nov; 106(11):1872-9. PubMed ID: 22056566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Guidelines for the treatment of anemia in chronic renal failure].
    Triolo G;
    G Ital Nefrol; 2003; 20 Suppl 24():S61-82. PubMed ID: 14666504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress, renal anemia, and its therapies: is there a link?
    Căpuşă C; Mircescu G
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S71-6. PubMed ID: 20797576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.